Form 8-K - Current report:
SEC Accession No. 0001193125-24-236782
Filing Date
2024-10-11
Accepted
2024-10-11 16:52:01
Documents
16
Period of Report
2024-10-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d835769d8k.htm   iXBRL 8-K 27508
2 EX-1.1 d835769dex11.htm EX-1.1 218365
3 EX-5.1 d835769dex51.htm EX-5.1 8346
7 GRAPHIC g835769g24y21.jpg GRAPHIC 10149
  Complete submission text file 0001193125-24-236782.txt   449830

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bntc-20241011.xsd EX-101.SCH 2888
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bntc-20241011_lab.xml EX-101.LAB 17237
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bntc-20241011_pre.xml EX-101.PRE 10838
18 EXTRACTED XBRL INSTANCE DOCUMENT d835769d8k_htm.xml XML 3485
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39267 | Film No.: 241368053
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)